Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gongxueting Granules is a Traditional Chinese Medicine (TCM) pharmaceutical product developed and manufactured by Shanxi Buchang Pharmaceutical. It is formulated as an oral granule and is primarily indicated for the treatment of abnormal uterine bleeding (AUB), including menorrhagia and metrorrhagia resulting from various etiologies. The herbal composition is designed to promote uterine contraction and achieve hemostasis by cooling the blood and resolving blood stasis, according to TCM principles. It is currently approved and marketed in China for gynecological applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gongxueting Granules.